Cancer preventive role of selected dietary factors

Indian Journal of Cancer

Volumn 42, Issue 1, 2005, Pages 11-20

  Amitabha, Ray ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer; Diet; Isothiocyanates; Micronutrients; Phenolic compounds

Indexed keywords

EID: 22244444473     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJL. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer 2002;2:37-62
2. Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJL. BMC Cancer 2003;3:20-5.
3. Weisburger JH. Lifestyle, health and disease prevention: The underlying mechanisms. Eur J Cancer Prev 2002;11:S1-7.
4. Kritchevsky D. Diet and cancer: What′s next? J Nutr 2003;133:3827S-9S.
5. Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr 2004;7:187-200.
6. Birt DF, Przybyszewski J, Wang W, Stewart J, Liu Y. Identification of molecular targets for dietary energy restriction prevention of skin carcinogenesis: An idea cultivated by Edward Bresnick. J Cell Biochem 2004;91:258-64.
7. Simopoulos AP. The traditional diet of Greece and cancer. Eur J Cancer Prev 2004;13:219-30.
8. de la Taille A, Katz A, Vacherot F, Saint F, Salomon L, Cicco A, et al. Cancer of the prostate: Influence of nutritional factors. A new nutritional approach. Presse Med 2001;30:561-4.
9. Prentice RL. Future possibilities in the prevention of breast cancer: Fat and fiber and breast cancer research. Breast Cancer Res 2000;2:268-76.
10. Reddy BS. Prevention of colon carcinogenesis by components of dietary fiber. Anticancer Res 1999;19:3681-3.
11. Reddy BS, Hirose Y, Cohen LA, Simi B, Cooma I, Rao CV. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: Implications for human colon cancer prevention. Cancer Res 2000;60:4792-7.
12. Alberts DS, Martinez ME, Roe DJ, Guillen-Rodriguez JM, Marshall JR, van Leeuwen JB, et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. New Engl J Med 2000;342:1156-62.
13. Astorg P. Dietary n-6 and n-3 polyunsaturated fatty acids and prostate cancer risk: A review of epidemiological and experimental evidence. Cancer Causes Control 2004;15:367-86.
14. Sinha R, Anderson DE, McDonald SS, Greenwald P. Cancer risk and diet in India. J Postgrad Med 2003;49:222-8.
15. Sporn MB, Roberts AB. Role of retinoids in differentiation and carcinogenesis. J Natl Cancer Inst 1984;73:1381-7.
16. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985;45:1-8.
17. Surh YJ. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res 1999;428:305-27.
18. Kong AN, Yu R, Hebbar V, Chen C, Owuor E, Hu R, et al. Signal transduction events elicited by cancer prevention compounds. Mutat Res 2001;480-1:231-41.
19. Chen C, Kong AN. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic Biol Med 2004;36:1505-16.
20. Gotay CC. Behavior and cancer prevention. J Clin Oncol 2005;23:301-10.
21. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-6.
22. Martinez ME. Primary prevention of colorectal cancer: Lifestyle, nutrition, exercise. Recent Results Cancer Res 2005;166:177-211.
23. Nowell SA, Ahn J, Ambrosone CB. Gene-nutrient interactions in cancer etiology. Nutr Rev 2004;62:427-38.
24. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997;6:733-43.
25. Mittal RD, Srivastava DSL, Mandhani A, Kumar A, Mittal B. Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: A study from North India. Indian J Cancer 2004;41:115-9.
26. Hursting SD, Lavigne JA, Berrigan D, Donehower LA, Davis BJ, Phang JM, et al. Diet-gene interactions in p53-deficient mice: Insulin-like growth factor-1 as a mechanistic target. J Nutr 2004;134:2482S-6S.
27. Patel AC, Nunez NP, Perkins SN, Barrett JC, Hursting SD. Effects of energy balance on cancer in genetically altered mice. J Nutr 2004:134:3394S-8S.
28. Doll R, Peto R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.
29. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, and the prevention of cancer: A global perspective. American Institute for Cancer Research, Washington, DC; 1997.
30. Stoeckli R, Keller U. Nutritional fats and the risk of type 2 diabetes and cancer. Physiol Behav 2004;83:611-5.
31. McCullough ML, Giovannucci EL. Diet and cancer prevention. Oncogene 2004;23:6349-64.
32. Michels KB. The role of nutrition in cancer development and prevention. Int J Cancer 2004;114:163-5.
33. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Toxicol Sci 1999;52:S13-6.
34. Platz EA. Energy imbalance and prostate cancer. J Nutr 2002;132:3471S-81S.
35. Kaaks R, Lukanova A. Energy balance and cancer: The role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001;60:91-106.
36. Kaaks R. Nutrition, insulin, IGF-I metabolism and cancer risk: A summary of epidemiological evidence. Novartis Found Symp 2004;262:247-60.
37. IARC Handbooks of Cancer Prevention. Fruit and vegetables (Vol 8). International Agency for Research on Cancer (WHO), Lyon 2003.
38. Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med 2004;50:145-9.
39. Casimiro C. Etiopathogenic factors in colorectal cancer. Nutritional and life-style aspects.2. Nutr Hosp 2002;17:128-38.
40. Wardlaw GM, Hempl JS, DiSilvestro RA. Perspectives in Nutrition. 6th Ed. New York: McGraw-Hill; 2004.
41. Moorman PG, Terry PD. Consumption of dairy products and the risk of breast cancer: A review of the literature. Am J Clin Nutr 2004;80:5-14.
42. Gill HS, Cross ML. Anticancer properties of bovine milk. Br J Nutr 2000;84:S161-6.
43. Norat T, Riboli E. Dairy products and colorectal cancer. A review of possible mechanisms and epidemiological evidence. Eur J Clin Nutr 2003;57:1-17.
44. Flood A, Peters U, Chatterjee N, Lacey JV Jr, Schairer C, Schatzkin A. Calcium from diet and supplements is associated with reduced risk of colorectal cancer in a prospective cohort of women. Cancer Epidemiol Biomarkers Prev 2005;14:126-32.
45. Hawk ET, Levin B. Colorectal cancer prevention. J Clin Oncol 2005;23:378-91.
46. Talalay P, Fahey JW. Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 2001;131:3027S-33S.
47. IARC Handbooks of Cancer Prevention. Cruciferous vegetables (Vol 9). International Agency for Research on Cancer (WHO), Lyon 2004.
48. Rosa EAS, Heaney RK, Fenwick GR, Portas CAM. Glucosinolates in crop plants. Hortic Rev 1997;19:99-215.
49. Lampe JW, Peterson S. Brassica, biotransformation and cancer risk: Genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr 2002;132:2991-4.
50. Fahey JW, Zalcmann AT, Talalay P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 2001;56:5-51.
51. Keck AS, Finley JW. Cruciferous vegetables: Cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integr Cancer Ther 2004;3:5-12.
52. Hecht SS. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 2000;32:395-411.
53. Singh SV, Herman-Antosiewicz A, Singh AV, Lew KL, Srivastava SK, Kamath R, et al. Sulforaphane -induced G2/M phase cell cycle arrest involves checkpoint kinase 2 -mediated phophorylation of cell division cycle 25C. J Biol Chem 2004;279:25813-22.
54. Longcope C. Relationships of estrogen to breast cancer, of diet to breast cancer, and of diet to estradiol metabolism. J Natl Cancer Inst 1990;82:96-7.
55. Michnovicz JJ, Adlercreutz H, Bradlow HL. Changes in levels of urinary estrogen metabolites after oral indole-3-carbinol treatment in humans. J Natl Cancer Inst 1997;89:718-23.
56. Brignall MS. Prevention and treatment of cancer with indole-3-carbinol. Altern Med Rev 2001;6:580-9.
57. Williamson G, Plumb GW, Uda Y, Price KR, Rhodes MJ. Dietary quercetin glycosides: Antioxidant activity and induction of the anticarcinogenic phase II marker enzyme quinone reductase in Hepalclc7 cells. Carcinogenesis 1996;17:2385-7.
58. Finley JW, Davis CD, Feng Y. Selenium from high selenium broccoli protects rats from colon cancer. J Nutr 2000;130:2384-9.
59. Jiang C, Hu H, Malewicz B, Wang Z, Lu J. Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. Mol Cancer Ther 2004;3:877-84.
60. Duthie GG, Gardner PT, Kyle JAM. Plant polyphenols: Are they the new magic bullet? Proc Nutr Soc 2003;62:599-603.
61. O'Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O'Brien NM, Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 2004;551:245-54.
62. Fujita T, Matsui M, Takaku K. Size and invasion dependent increase in cyclooxygenase-2 levels in human colorectal carcinomas. Cancer Res 1998;58:4823-6.
63. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999;20:1945-52.
64. Singh RP, Agarwal R. Prostate cancer prevention by silibinin. Curr Cancer Drugs Targets 2004;4:1-11.
65. Limer JL, Speirs V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res 2004;6:119-27.
66. Wagner KH, Elmadfa I. Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes. Ann Nutr Metab 2003;47:95-106.
67. Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr 1999;129:775S-8S.
68. Johnson EJ. The role of carotenoids in human health. Nutr Clin Care 2002;5:56-65.
69. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J Natl Cancer Inst 1999;91:317-31.
70. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-35.
71. Omenn GS, Goodman GE, Thornquist MD, Grizzle J, Rosenstock L, Barnhart S, et al. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers. Cancer Res 1994;54:2038s-43s.
72. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL Jr, Omenn GS, et al. The Beta-carotene and Retinol Efficacy Trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 2004;96:1743-50.
73. Toma S, Bonelli L, Sartoris A, Mira E, Antonelli A, Beatrice F, et al. Beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: Results of a randomized trial. Oncol Rep 2003;10:1895-901.
74. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: The Women′s Health Study. J Natl Cancer Inst 1999;91:2102-6.
75. Cook NR, Lee IM, Manson JE, Buring JE, Hennekens CH. Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians′ Health Study (United States). Cancer Causes Control 2000;11:617-26.
76. Baron JA, Cole BF, Mott L, Haile R, Grau M, Church TR, et al. Neoplastic and antineoplastic effects of beta-carotene on colorectal adenoma recurrence: Results of a randomized trial. J Natl Cancer Inst 2003;95:717-22.
77. Liu C, Russell RM, Wang XD. Exposing ferrets to cigarette smoke and a pharmacological dose of β-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J Nutr 2003;133:173-9.
78. Bendich A. From 1989 to 2001: What have we learned about the "biological actions of beta-carotene"? J Nutr 2004;134:225S-30S.
79. Dragnev KH, Rigas JR, Dmitrovsky E. The retinoids and cancer prevention mechanisms. Oncologist 2000;5:361-8.
80. Duffield-Lillico AJ, Begg CB. Reflections on the landmark studies of β-carotene supplementation. J Natl Cancer Inst 2004;96:1729-31.
81. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003;78:559S-69S.
82. Huang C, Huang Y, Li J, Hu W, Aziz R, Tang MS, et al. Inhibition of benzo(a)pyrene diol-epoxide -induced transactivation of activated protein 1 and nuclear factor kappa B by black raspberry extracts. Cancer Res 2002;62:6857-63.
83. Whitley AC, Stoner GD, Darby MV, Walle T. Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid - extensive binding to protein and DNA. Biochem Pharmacol 2003:66:907-15.
84. Jannin B, Menzel M, Berlot JP, Delmas D, Lancon A, Latruffe N. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: Plasmatic protein binding and cell uptake. Biochem Pharmacol 2004;68:1113-8.
85. Granados-Soto V. Pleiotropic effects of resveratrol. Drug News Perspect 2003;16:299-307.
86. Einspahr JG, Bowden GT, Alberts DS. Skin cancer chemoprevention: Strategies to save our skin. Recent Results Cancer Res 2003;163:151-64.
87. Ding M, Lu Y, Bowman L, Huang C, Leonard S, Wang L, et al. Inhibition of AP-1 and neoplastic transformation by fresh apple peel extract. J Biol Chem 2004;279:10670-6.
88. Liu G, Bode A, Ma WY, Sang S, Ho CT, Dong Z. Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res 2001;61:5749-56.
89. Liao CH, Sang S, Liang YC, Ho CT, Lin JK. Suppression of inducible nitric oxide synthase and cyclooxygenase-2 in downregulating nuclear factor-kappa B pathway by garcinol. Mol Carcinog 2004;41:140-9.
90. Il'yasova D, Martin C, Sandler RS. Tea intake and risk of colon cancer in African-Americans and whites: North Carolina colon cancer study. Cancer Causes Control 2003;14:767-72.
91. Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother Pharmacol 2005;55:33-8.
92. Sasazuki S, Inoue M, Hanaoka T, Yamamoto S, Sobue T, Tsugane S. Green tea consumption and subsequent risk of gastric cancer by subsite: The JPHC Study. Cancer Causes Control 2004;15:483-91.
93. Zhang M, Lee AH, Binns CW, Xie X. Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer 2004;112:465-9.
94. Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr 2003;133:3262S-7S.
95. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002;42:25-54.
96. Chung FL, Schwartz J, Herzog CR, Yang YM. Tea and cancer prevention: Studies in animals and humans. J Nutr 2003;133:3268S-74S.
97. Masuda M, Suzui M, Lim JT, Weinstein IB. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin Cancer Res 2003;9:3486-91.
98. Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J Exp Ther Oncol 2002;2:350-9.
99. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003;23:363-98.
100. Leu TH, Maa MC. The molecular mechanisms for the antitumorigenic effect of curcumin. Curr Med Chem Anti-Canc Agents 2002;2:357-70.
101. Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des 2002;8:1695-706.
102. Mustafa T, Srivastava KC, Jensen KB. Drug development report (9): pharmacology of ginger, Zingiber officinale. J Drug Dev 1993;6:25-39.
103. Aeschbach R, Loliger J, Scott BC, Murcia A, Butler J, Halliwell B, et al. Antioxidant actions of thymol, carbacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem Toxicol 1994;32:31-6.
104. Surh YJ. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: A short review. Food Chem Toxicol 2002;40:1091-7.
105. Lopez-Carrillo L, Lopez-Cervantes M, Robles-Diaz G, Ramirez-Espitia A, Mohar-Betancourt A, Meneses-Garcia A, et al. Capsaicin consumption, Helicobacter pylori positivity and gastric cancer in Mexico. Int J Cancer 2003;106:277-82.
106. Plummer M, Franceschi S, Munoz N. Epidemiology of gastric cancer. IARC Sci Publ 2004;157:311-26.
107. Hail N. Mechanisms of vanilloid-induced apoptosis. Apoptosis 2003;8:251-62.
108. Murakami A, Takahashi D, Hagihara K, Koshimizu K, Ohigashi H. Combinatorial effects of nonsteroidal anti-inflammatory drugs and food constituents on production of prostaglandin E2 and tumor necrosis factor-alpha in RAW264.7 murine macrophages. Biosci Biotechnol Biochem 2003;67:1056-62.